VA and HHS Launch New Psychedelic Therapy Partnership for Veterans
The new partnership aims to expand research on psychedelic therapies to improve veteran mental health care.

What's Happening
- •The VA and HHS have initiated a partnership to advance psychedelic therapy research.
- •This initiative is expected to impact over 1 million veterans seeking mental health treatment.
- •The partnership aims to prepare the VA for integrating psychedelic therapies into veteran care.
Why It Matters
This partnership represents a pivotal shift in how the VA approaches mental health care for veterans. By exploring psychedelic therapies, the VA aims to provide more effective treatment options for those grappling with conditions like PTSD, which disproportionately affect military personnel.
What Changes Now
- •The VA is initiating research on psychedelic therapies starting immediately. This means veterans can expect updates on new treatment options as research progresses.
- •Healthcare providers within the VA will begin training to integrate these therapies into their practices. This change is crucial for ensuring that veterans receive the most current and effective mental health care.
- •Veterans are encouraged to discuss their mental health needs with their providers. This proactive approach can help identify if they qualify for upcoming clinical trials related to psychedelic therapy.
What to Watch
- •Upcoming clinical trials related to psychedelic therapies will be announced in the next few months. Veterans should monitor VA communications for eligibility and participation details.
- •The timeline for research findings is expected to be released within the next year. This information will be critical in understanding when new therapies might become available.
- •Discussions regarding the safety and efficacy of psychedelic treatments will continue in the medical community. Veterans should stay informed about these developments as they may influence treatment options.
Get the Daily Briefing
Military and veteran news that actually affects you, in your inbox each morning.
More Context
- •Understanding the Partnership: The new partnership between the Department of Veterans Affairs (VA) and the Department of Health and Human Services (HHS) marks a significant step in mental health care for veterans. This collaboration is focused on accelerating research into psychedelic therapies, which have shown promise in treating conditions like PTSD and depression. By pooling resources and expertise, the VA aims to enhance its capabilities in providing innovative treatment options for veterans who have struggled with traditional therapies.
- •Impact on Veteran Care: This initiative will directly benefit veterans suffering from mental health issues, particularly those who have not found relief through conventional treatments. The research stemming from this partnership is expected to lead to the development of new therapeutic protocols that could be implemented within the VA healthcare system. As the VA prepares to integrate these therapies, veterans can anticipate more comprehensive and effective treatment options tailored to their unique needs.
- •What Veterans Should Know: Veterans interested in these new therapy options should stay informed about upcoming clinical trials and studies that may be available through the VA. It is essential for veterans to communicate with their healthcare providers about their mental health needs and inquire about potential participation in these innovative treatment programs. The VA will likely provide updates on eligibility criteria and enrollment processes as research progresses.
- •Future Considerations: As the partnership unfolds, veterans should watch for developments regarding the timeline for research findings and the potential rollout of new therapies. The success of this initiative could reshape the landscape of mental health care within the VA, making it crucial for veterans to remain engaged with their care teams. Additionally, ongoing discussions in the medical community regarding the efficacy and safety of psychedelic treatments will be vital in determining how these therapies are implemented.
Frequently Asked Questions
Will I be able to access psychedelic therapy through the VA?
Access to psychedelic therapy will depend on the outcomes of ongoing research and subsequent program implementation by the VA.
How can I participate in clinical trials for psychedelic therapy?
Veterans should consult with their healthcare providers at the VA to express interest in participating in clinical trials as they become available.
Key Takeaways
- •The VA and HHS are collaborating to enhance psychedelic therapy research for veterans.
- •Over 1 million veterans could benefit from advancements in mental health treatment.
- •Veterans should communicate with their healthcare providers about new therapy options.
The Daily Briefing
Military & veteran news that actually affects you — delivered every morning.
- Pay, benefits & policy changes
- Pentagon decisions that matter
- VA updates for veterans & families
- One email. No spam. Unsubscribe anytime.
Related Stories
- Col. Frank Cohn, WWII Veteran of the Battle of the Bulge, Dies at 100— Military Times
- Navy Christens Flight III Arleigh Burke-class Destroyer After Korean War Hero— Military Times
- 8 Meaningful Ways to Show Appreciation for Veterans on Veterans Day— Military.com
- Bost, Who Defended ‘Radical’ Speech, Wants VFW Scrutinized for TCAVA Stance— Military.com